Fennec Pharmaceuticals Inc. Common Stock FENC

$10.71 +0.75% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 Insider transaction 2026-10-01 View →
4 Insider transaction 2026-10-01 View →
4 Insider transaction 2026-10-01 View →
4 Insider transaction 2026-10-01 View →
4 Insider transaction 2026-10-01 View →
8-K 8-K 2026-09-17 View →
4 Insider transaction 2026-09-16 View →
4 Insider transaction 2026-09-01 View →
4 Insider transaction 2026-08-31 View →
4 Insider transaction 2026-08-31 View →
4 Insider transaction 2026-08-31 View →
4 Insider transaction 2026-08-31 View →
4 Insider transaction 2026-08-31 View →
4 Insider transaction 2026-08-28 View →
10-Q 10-Q 2026-08-13 View →
4 Insider transaction 2026-08-04 View →
4 Insider transaction 2026-08-03 View →
4 Insider transaction 2026-08-03 View →
4 Insider transaction 2026-08-03 View →
4 Insider transaction 2026-08-03 View →
4 Insider transaction 2026-08-03 View →
4 Insider transaction 2026-08-03 View →
4 Insider transaction 2026-07-02 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-07-01 View →
4 Insider transaction 2026-06-10 View →
4 Insider transaction 2026-06-10 View →
4 Insider transaction 2026-06-10 View →
4 Insider transaction 2026-06-10 View →
8-K FORM 8-K 2026-06-10 View →
4 Insider transaction 2026-06-02 View →
4 Insider transaction 2026-06-01 View →
4 Insider transaction 2026-06-01 View →
4 Insider transaction 2026-06-01 View →
4 Insider transaction 2026-06-01 View →
4 Insider transaction 2026-06-01 View →
8-K 8-K 2026-05-22 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$10.71
Market Cap
$372.76 million
52-Week Range
$5.65 – $13.25
Average Volume
194K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.